Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9963)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2013 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pompili M, Francica G, Ponziani FR, Iezzi R, Avolio AW. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation. World J Gastroenterol 2013; 19(43): 7515-7530 [PMID: 24282343 DOI: 10.3748/wjg.v19.i43.7515] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i43/7515.htm |
| Number | Citing Articles |
| 1 |
Alberto Unzueta, Roniel Cabrera. Treatment Options in Patients Awaiting Liver Transplantation with Hepatocellular Carcinoma and Cholangiocarcinoma. Clinics in Liver Disease 2017; 21(2): 231 doi: 10.1016/j.cld.2016.12.002
|
| 2 |
René Fahrner, Felix Dondorf, Michael Ardelt, Yves Dittmar, Utz Settmacher, Falk Rauchfuß. Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival. World Journal of Gastroenterology 2015; 21(42): 12071-12082 doi: 10.3748/wjg.v21.i42.12071
|
| 3 |
Vatche G. Agopian, Michael P. Harlander-Locke, Richard M. Ruiz, Goran B. Klintmalm, Srinath Senguttuvan, Sander S. Florman, Brandy Haydel, Maarouf Hoteit, Matthew H. Levine, David D. Lee, C. Burcin Taner, Elizabeth C. Verna, Karim J. Halazun, Rita Abdelmessih, Amit D. Tevar, Abhinav Humar, Federico Aucejo, William C. Chapman, Neeta Vachharajani, Mindie H. Nguyen, Marc L. Melcher, Trevor L. Nydam, Constance Mobley, R. Mark Ghobrial, Beth Amundsen, James F. Markmann, Alan N. Langnas, Carol A. Carney, Jennifer Berumen, Alan W. Hemming, Debra L. Sudan, Johnny C. Hong, Joohyun Kim, Michael A. Zimmerman, Abbas Rana, Michael L. Kueht, Christopher M. Jones, Thomas M. Fishbein, Ronald W. Busuttil. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation. Annals of Surgery 2017; 266(3): 525 doi: 10.1097/SLA.0000000000002381
|
| 4 |
Anjana Pillai, Thomas Couri, Michael Charlton. Liver Allocation Policies in the USA: Past, Present, and the Future. Digestive Diseases and Sciences 2019; 64(4): 985 doi: 10.1007/s10620-019-05549-y
|
| 5 |
Tadahiro Uemura, Alexander Kirichenko, Mark Bunker, Molly Vincent, Lorenzo Machado, Ngoc Thai. Stereotactic Body Radiation Therapy: A New Strategy for Loco‐Regional Treatment for Hepatocellular Carcinoma While Awaiting Liver Transplantation. World Journal of Surgery 2019; 43(3): 886 doi: 10.1007/s00268-018-4829-x
|
| 6 |
Thomas Couri, Anjana Pillai. Goals and targets for personalized therapy for HCC. Hepatology International 2019; 13(2): 125 doi: 10.1007/s12072-018-9919-1
|
| 7 |
Heloise Giudicelli, Charles Roux, Antoine Monsel, Filomena Conti, Olivier Scatton, Manon Allaire. Successful advanced hepatocellular carcinoma downstaging with atezolizumab-Bevacizumab and radioembolization before liver transplantation. Clinics and Research in Hepatology and Gastroenterology 2023; 47(7): 102167 doi: 10.1016/j.clinre.2023.102167
|
| 8 |
Tiffany Cho‐Lam Wong, Victor Ho‐Fun Lee, Ada Lai‐Yau Law, Herbert H. Pang, Ka‐On Lam, Vince Lau, Tracy Yushi Cui, Adrianna Sze‐Yin Fong, Sarah Wai‐Man Lee, Edwin Chun‐Yin Wong, Jeff Wing‐Chiu Dai, Albert Chi‐Yan Chan, Tan‐To Cheung, James Yan‐Yue Fung, Rebecca Mei‐Wan Yeung, Mai‐Yee Luk, To‐Wai Leung, Chung‐Mau Lo. Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant. Hepatology 2021; 74(5): 2580 doi: 10.1002/hep.31992
|
| 9 |
|
| 10 |
L. Reguera-Berenguer, J. Orcajo-Rincón, A. Rotger-Regí, A.M. Matilla-Peña, M. Echenagusia-Boyra, R. Pérez-Pascual, A. Marí-Hualde, J.C. Alonso-Farto. Downstaging of bilobar hepatocellular carcinoma after radioembolization with 90 Y microspheres as a bridge to liver transplantation. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2017; 36(5): 329 doi: 10.1016/j.remnie.2017.06.005
|
| 11 |
Armin Finkenstedt, Anja Vikoler, Manuela Portenkirchner, Kerstin Mülleder, Manuel Maglione, Christian Margreiter, Patrizia Moser, Wolfgang Vogel, Reto Bale, Martin Freund, Anna Luger, Herbert Tilg, Johannes Petersen, Stefan Schneeberger, Ivo Graziadei, Heinz Zoller, Bernhard Glodny. Excellent post‐transplant survival in patients with intermediate stage hepatocellular carcinoma responding to neoadjuvant therapy. Liver International 2016; 36(5): 688 doi: 10.1111/liv.12966
|
| 12 |
Eliza W. Beal, Kristin M. Dittmar, A. James Hanje, Anthony J. Michaels, Lanla Conteh, Gail Davidson, Sylvester M. Black, P. Mark Bloomston, Mary E. Dillhoff, Carl R. Schmidt. Pretransplant Locoregional Therapy for Hepatocellular Carcinoma: Evaluation of Explant Pathology and Overall Survival. Frontiers in Oncology 2016; 6 doi: 10.3389/fonc.2016.00143
|
| 13 |
Sirish Kishore, Tamir Friedman, David C. Madoff. Update on Embolization Therapies for Hepatocellular Carcinoma. Current Oncology Reports 2017; 19(6) doi: 10.1007/s11912-017-0597-2
|
| 14 |
Hyung-Don Kim, Gi-Won Song, Ju Hyun Shim, Seungbong Han, Jihyun An, Deok-Bog Moon, Kang Mo Kim, Young-Suk Lim, Gi-Young Ko, Shin Hwang, Han Chu Lee, Eunsil Yu, Kyu-Bo Sung, Sung-Gyu Lee. Clinical validity of Metroticket calculator in transplant patients undergoing prior chemoembolization for hepatocellular carcinoma. Hepatology International 2017; 11(2): 209 doi: 10.1007/s12072-017-9785-2
|
| 15 |
Adeel S Khan, Kathryn J Fowler, William C Chapman. Current surgical treatment strategies for hepatocellular carcinoma in North America. World Journal of Gastroenterology 2014; 20(41): 15007-15017 doi: 10.3748/wjg.v20.i41.15007
|
| 16 |
Ana-Maria Bucalau, Illario Tancredi, Gontran Verset. In the Era of Systemic Therapy for Hepatocellular Carcinoma Is Transarterial Chemoembolization Still a Card to Play?. Cancers 2021; 13(20): 5129 doi: 10.3390/cancers13205129
|
| 17 |
Anil Seetharam, Robert Perrillo, Robert Gish. Immunosuppression in Patients with Chronic Hepatitis B. Current Hepatology Reports 2014; 13(3): 235 doi: 10.1007/s11901-014-0238-2
|
| 18 |
Georg P. Györi, D. Moritz Felsenreich, Gerd R. Silberhumer, Thomas Soliman, Gabriela A. Berlakovich. Multimodality locoregional treatment strategies for bridging HCC patients before liver transplantation. European Surgery 2017; 49(5): 236 doi: 10.1007/s10353-017-0487-8
|
| 19 |
Wan Yee Lau, Yee Leong Teoh, Khin Maung Win, Rheun-Chuan Lee, Vanessa H de Villa, Yun Hwan Joseph Kim, Po-Chin Liang, Ramon S Santos-Ocampo, Richard Hoau Gong Lo, Kieron Boon Leng Lim, David Wai Meng Tai, David Chee Eng Ng, Farah Gillan Irani, Apoorva Gogna, Pierce Kah-Hoe Chow. Current role of selective internal radiation with yttrium-90 in liver tumors. Future Oncology 2016; 12(9): 1193 doi: 10.2217/fon-2016-0035
|
| 20 |
Emina Talakić, Elmar Janek, Saulius Mikalauskas, Peter Schemmer. Liver Transplantation in Malignancies: A Comprehensive and Systematic Review on Oncological Outcome. Visceral Medicine 2021; 37(4): 302 doi: 10.1159/000517328
|
| 21 |
Amanda Pinter Carvalheiro da Silva Boteon, Yuri Longatto Boteon, Eduardo F. Vinuela, Carlos Derosas, Hynek Mergental, John R. Isaac, Paolo Muiesan, Homoyoon Mehzard, Yuk Ting Ma, Tahir Shah, Darius F. Mirza, M. Thamara P. R. Perera. The impact of transarterial chemoembolization induced complications on outcomes after liver transplantation: A propensity‐matched study. Clinical Transplantation 2018; 32(5) doi: 10.1111/ctr.13255
|
| 22 |
Lei Xu, Lin Chen, Wei Zhang. Neoadjuvant treatment strategies for hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2021; 13(12): 1550-1566 doi: 10.4240/wjgs.v13.i12.1550
|
| 23 |
Alfonso Jose Holguín Holguín, Juan Sebastián Toro Gutierrez, Luis Alfonso Bustamante-Cristancho, Tatiana Alvarez Saa, Juan C. Camacho. Bland Embolization and Transarterial Chemoembolization in Hepatocarcinoma. Digestive Disease Interventions 2024; 8(01): 52 doi: 10.1055/s-0043-1772742
|
| 24 |
Lauren Matevish, Madhukar S. Patel, Parsia A. Vagefi. Downstaging Techniques for Hepatocellular Carcinoma in Candidates Awaiting Liver Transplantation. Surgical Clinics of North America 2024; 104(1): 145 doi: 10.1016/j.suc.2023.07.004
|
| 25 |
Sunyoung Lee, Kyoung Won Kim, Gi-Won Song, Jae Hyun Kwon, Shin Hwang, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Gil-Chun Park, Sung-Gyu Lee. The Real Impact of Bridging or Downstaging on Survival Outcomes after Liver Transplantation for Hepatocellular Carcinoma. Liver Cancer 2020; 9(6): 721 doi: 10.1159/000507887
|
| 26 |
Tyler Sandow, John Pavlus, David Field, Eduardo Lacayo, Emil Cohen, George Lynskey, Theresa Caridi, Donna Buckley, John Cardella, Bhaskar Kallakury, James Spies, Alexander Y. Kim. Bridging Hepatocellular Carcinoma to Transplant: Transarterial Chemoembolization Response, Tumor Biology, and Recurrence after Transplantation in a 12-Year Transplant Cohort. Journal of Vascular and Interventional Radiology 2019; 30(7): 995 doi: 10.1016/j.jvir.2018.12.736
|
| 27 |
Badar Hasan, Yasar Colak, Rumman A. Khalid, Michael Castillo, Daniel Castaneda, Kanwarpreet Tandon, Joshua J. Shaw, Tolga Erim, Xaralambos B. Zervos, Fernando J. Castro, Kawtar Al-Khalloufi. Early Detection of Hepatocellular Carcinoma Recurrence in the Posttransplant Population: A Comparison of RETREAT and Cleveland Clinic Florida Scoring System. Transplantation Proceedings 2021; 53(1): 193 doi: 10.1016/j.transproceed.2020.09.015
|
| 28 |
Zenichi Morise, Norihiko Kawabe, Hirokazu Tomishige, Hidetoshi Nagata, Jin Kawase, Satoshi Arakawa, Rie Yoshida, Masashi Isetani. Recent advances in the surgical treatment of hepatocellular carcinoma. World Journal of Gastroenterology 2014; 20(39): 14381-14392 doi: 10.3748/wjg.v20.i39.14381
|
| 29 |
Farnaz Najmi Varzaneh, Ankur Pandey, Mounes Aliyari Ghasabeh, Nannan Shao, Pegah Khoshpouri, Pallavi Pandey, Manijeh Zarghampour, Daniel Fouladi, Robert Liddell, Robert Albert Anders, Ihab R. Kamel.
Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation
. European Radiology 2018; 28(7): 3032 doi: 10.1007/s00330-017-5198-9
|
| 30 |
Wei-Xiong Lim, Kuan Siong Sim, Chao-Long Chen, Hsin-You Ou, Chun-Yen Yu, Yu-Fan Cheng. Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma: The Effectiveness of Different Particle Sizes in Downstaging and Bridging in Living Donor Liver Transplantation. Transplantation Proceedings 2024; doi: 10.1016/j.transproceed.2024.01.062
|
| 31 |
Danijel Galun, Dragana Mijac, Aleksandar Filipovic, Aleksandar Bogdanovic, Marko Zivanovic, Dragan Masulovic. Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective. Journal of Personalized Medicine 2022; 12(2): 149 doi: 10.3390/jpm12020149
|
| 32 |
Brianna Ruch, Josiah Wagler, Kayla Kumm, Chi Zhang, Nitin N. Katariya, Mauricio Garcia-Saenz-de-Sicilia, Emmanouil Giorgakis, Amit K. Mathur. Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future. Current Oncology 2022; 29(10): 7537 doi: 10.3390/curroncol29100593
|
| 33 |
Si-Yuan Wang, Kai Sun, Shuo Jin, Kai-Yu Wang, Nan Jiang, Si-Qiao Shan, Qian Lu, Guo-Yue Lv, Jia-Hong Dong. Predicting the outcomes of hepatocellular carcinoma downstaging with the use of clinical and radiomics features. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11386-0
|
| 34 |
Susan Shamimi-Noori. Contemporary Liver Transplantation. 2016; : 1 doi: 10.1007/978-3-319-05543-5_23-1
|
| 35 |
Shamar Young, Jafar Golzarian. Locoregional Therapies in the Treatment of 3- to 5-cm Hepatocellular Carcinoma: Critical Review of the Literature. American Journal of Roentgenology 2020; 215(1): 223 doi: 10.2214/AJR.19.22098
|
| 36 |
Andrew R. Kolarich, Tanveen Ishaque, Jessica Ruck, Alex J. Solomon, Allan Massie, Dorry L. Segev, Ahmet Gurakar, Andrew Cameron, Christos Georgiades, Kelvin Hong, Jaqueline Garonzik-Wang. Radiofrequency Ablation versus Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Awaiting Liver Transplant: An Analysis of the Scientific Registry of Transplant Recipients. Journal of Vascular and Interventional Radiology 2022; 33(10): 1222 doi: 10.1016/j.jvir.2022.06.016
|
| 37 |
Roberto Minici, Maria Anna Siciliano, Michele Ammendola, Rita Carlotta Santoro, Vito Barbieri, Girolamo Ranieri, Domenico Laganà. Prognostic Role of Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR), Platelet-to-Lymphocyte Ratio (PLR) and Lymphocyte-to-C Reactive Protein Ratio (LCR) in Patients with Hepatocellular Carcinoma (HCC) undergoing Chemoembolizations (TACE) of the Liver: The Unexplored Corner Linking Tumor Microenvironment, Biomarkers and Interventional Radiology. Cancers 2022; 15(1): 257 doi: 10.3390/cancers15010257
|
| 38 |
Sandeep A. Ponniah, Andreas G. Zori, Roniel Cabrera. Liver Cancer. 2021; : 127 doi: 10.36255/exonpublications.livercancer.2021.ch7
|
| 39 |
Thomas J Byrne, Jorge Rakela. Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy. World Journal of Transplantation 2016; 6(2): 306-313 doi: 10.5500/wjt.v6.i2.306
|
| 40 |
Yuna Kim, Han Ah Lee, Jae Seung Lee, Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Soon Ho Um, Yeon Seok Seo, Seung Up Kim. Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma. Cancer Investigation 2021; 39(3): 274 doi: 10.1080/07357907.2020.1870126
|
| 41 |
Naik Vietti Violi, Jeffrey Gnerre, Amy Law, Stefanie Hectors, Octavia Bane, John Doucette, Ghadi Abboud, Edward Kim, Myron Schwartz, M Isabel Fiel, Bachir Taouli. Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology. European Radiology 2022; 32(9): 6493 doi: 10.1007/s00330-022-08732-4
|
| 42 |
Marcello Di Martino, Daniele Ferraro, Donatella Pisaniello, Giuseppe Arenga, Federica Falaschi, Alfonso Terrone, Marilisa Maniscalco, Alfonso Galeota Lanza, Ciro Esposito, Giovanni Vennarecci. Bridging therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta‐analysis on intention‐to‐treat outcomes. Journal of Hepato-Biliary-Pancreatic Sciences 2023; 30(4): 429 doi: 10.1002/jhbp.1248
|
| 43 |
Jean-Luc Raoul, Alejandro Forner, Luigi Bolondi, Tan To Cheung, Roman Kloeckner, Thierry de Baere. Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence. Cancer Treatment Reviews 2019; 72: 28 doi: 10.1016/j.ctrv.2018.11.002
|
| 44 |
|
| 45 |
Tamás Benkö, Julia König, Jens M. Theysohn, Clemens Schotten, Fuat H. Saner, Jürgen Treckmann, Sonia Radunz. Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?. European Journal of Medical Research 2022; 27(1) doi: 10.1186/s40001-022-00708-w
|
| 46 |
L. Reguera-Berenguer, J. Orcajo-Rincón, A. Rotger-Regí, A.M. Matilla-Peña, M. Echenagusia-Boyra, R. Pérez-Pascual, A. Marí-Hualde, J.C. Alonso-Farto. Downstaging de carcinoma hepatocelular bilobar tras radioembolización con microesferas de 90 Y como puente al trasplante hepático. Revista Española de Medicina Nuclear e Imagen Molecular 2017; 36(5): 329 doi: 10.1016/j.remn.2016.12.006
|
| 47 |
David J. Pinato, Sam M Murray, Alejandro Forner, Takahiro Kaneko, Petros Fessas, Pierluigi Toniutto, Beatriz Mínguez, Valentina Cacciato, Claudio Avellini, Alba Diaz, Rosemary J. Boyton, Daniel M. Altmann, Robert D Goldin, Ayse U Akarca, Teresa Marafioti, Francesco A Mauri, Edoardo Casagrande, Federica Grillo, Edoardo Giannini, Sherrie Bhoori, Vincenzo Mazzaferro. Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.. Journal for ImmunoTherapy of Cancer 2021; 9(9): e003311 doi: 10.1136/jitc-2021-003311
|
| 48 |
Benjamin Koh, Darren Jun Hao Tan, Wen Hui Lim, Jeffrey S L Wong, Cheng Han Ng, Kai En Chan, Meng Wang, Wei Peng Yong, Yock Young Dan, Louis Z Wang, Nigel Tan, Mark Muthiah, Alfred Kow, Nicholas L. Syn, Daniel Q. Huang, Thomas Yau. Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma. OncoImmunology 2023; 12(1) doi: 10.1080/2162402X.2023.2214478
|
| 49 |
Susan Shamimi-Noori. Contemporary Liver Transplantation. 2017; : 427 doi: 10.1007/978-3-319-07209-8_23
|
| 50 |
Roberto Iezzi, Maurizio Pompili, Michele Fabio La Torre, Maria Chiara Campanale, Martina Montagna, Antonio Saviano, Valentina Cesario, Massimo Siciliano, Eleonora Annicchiarico, Salvatore Agnes, Felice Giuliante, Antonio Grieco, Gian Lodovico Rapaccini, Anna Maria De Gaetano, Antonio Gasbarrini, Lorenzo Bonomo. Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma. Digestive and Liver Disease 2015; 47(3): 242 doi: 10.1016/j.dld.2014.12.007
|
| 51 |
Chan Woo Cho, Gyu-Seong Choi, Jong Man Kim, Choon Hyuck David Kwon, Doo Jin Kim, Jae-Won Joh. Clinical usefulness of transarterial chemoembolization response prior to liver transplantation as predictor of optimal timing for living donor liver transplantation. Annals of Surgical Treatment and Research 2018; 95(2): 111 doi: 10.4174/astr.2018.95.2.111
|
| 52 |
D. A. Granov, A. S. Polehin, P. G. Tarazov, I. O. Rutkin, I. I. Tileubergenov, V. V. Borovik. Transcatheter hepatic arterial chemoembolization in cirrhotic patients with hepatocellular carcinoma before liver transplantation: the prognostic value of alpha-fetoprotein concentrations. Russian Journal of Transplantology and Artificial Organs 2021; 22(4): 52 doi: 10.15825/1995-1191-2020-4-52-57
|
| 53 |
Vatche G. Agopian, Maud M. Morshedi, Justin McWilliams, Michael P. Harlander-Locke, Daniela Markovic, Ali Zarrinpar, Fady M. Kaldas, Douglas G. Farmer, Hasan Yersiz, Jonathan R. Hiatt, Ronald W. Busuttil. Complete Pathologic Response to Pretransplant Locoregional Therapy for Hepatocellular Carcinoma Defines Cancer Cure After Liver Transplantation. Annals of Surgery 2015; 262(3): 536 doi: 10.1097/SLA.0000000000001384
|
| 54 |
Alessandro Tropea, Marco Barbara, Sergio Calamia, Laura Lomaglio, Pasquale Bonsignore, Fabrizio Di Francesco, Duilio Pagano, Salvatore Gruttadauria. Laparoscopic Microwave Thermal Ablation for the Treatment of Hepatocellular Carcinoma in Chronic Hepatic Patients. Journal of Laparoendoscopic & Advanced Surgical Techniques 2020; 30(10): 1072 doi: 10.1089/lap.2020.0513
|
| 55 |
Samdeep K. Mouli, Laura W. Goff. Local Arterial Therapies in the Management of Unresectable Hepatocellular Carcinoma. Current Treatment Options in Oncology 2017; 18(11) doi: 10.1007/s11864-017-0509-6
|
| 56 |
Jonathan Klein, Renee Korol, Simon S Lo, William Chu, Michael Lock, Jennifer A Dorth, Rodney J Ellis, Nina A Mayr, Zhibin Huang, Hans T Chung. Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma. Future Oncology 2014; 10(14): 2227 doi: 10.2217/fon.14.167
|
| 57 |
Katherine S. Cools, Andrew M. Moon, Lauren M. B. Burke, Katrina A. McGinty, Paula D. Strassle, David A. Gerber. Validation of the Liver Imaging Reporting and Data System Treatment Response Criteria After Thermal Ablation for Hepatocellular Carcinoma. Liver Transplantation 2020; 26(2): 203 doi: 10.1002/lt.25673
|
| 58 |
Sami Akbulut, Tevfik Tolga Sahin. Comment on experience with LDLT in patients with hepatocellular carcinoma and portal vein tumor thrombosis postdownstaging. International Journal of Surgery Case Reports 2020; 74: 36 doi: 10.1016/j.ijscr.2020.07.057
|
| 59 |
Rachel Hogen, Mary Lo, Joseph DiNorcia, Lingyun Ji, Yuri Genyk, Linda Sher, Kiran Dhanireddy. More Than Just Wait Time? Regional Differences in Liver Transplant Outcomes for Hepatocellular Carcinoma. Transplantation 2019; 103(4): 747 doi: 10.1097/TP.0000000000002248
|
| 60 |
Jason Wachsmann, Fangyu Peng. Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(1): 221-231 doi: 10.3748/wjg.v22.i1.221
|
| 61 |
Kohei Ogawa, Toshimi Kaido, Hideaki Okajima, Yasuhiro Fujimoto, Atsushi Yoshizawa, Shintaro Yagi, Tomohide Hori, Taku Iida, Yasutsugu Takada, Shinji Uemoto. Impact of pretreatments on outcomes after living donor liver transplantation for hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2019; 26(2): 73 doi: 10.1002/jhbp.602
|
| 62 |
Clifford Akateh, Sylvester M Black, Lanla Conteh, Eric D Miller, Anne Noonan, Eric Elliott, Timothy M Pawlik, Allan Tsung, Jordan M Cloyd. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(28): 3704-3721 doi: 10.3748/wjg.v25.i28.3704
|
| 63 |
Marta Guerrero-Misas, Manuel Rodríguez-Perálvarez, Manuel De la Mata. Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World Journal of Hepatology 2015; 7(4): 649-661 doi: 10.4254/wjh.v7.i4.649
|
| 64 |
Shuhua Ma, Ping Zhou, Xiaomin Wu, Shuangming Tian, Yongfeng Zhao. Detection of the Single-Session Complete Ablation Rate by Contrast-Enhanced Ultrasound during Ultrasound-Guided Laser Ablation for Benign Thyroid Nodules: A Prospective Study. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/9565364
|
| 65 |
Jian‐Jian Chen, Zhi‐Cheng Jin, Bin‐Yan Zhong, Wenzhe Fan, Wei‐Hua Zhang, Biao Luo, Yu‐Qing Wang, Gao‐Jun Teng, Hai‐Dong Zhu. Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives. United European Gastroenterology Journal 2024; 12(2): 226 doi: 10.1002/ueg2.12554
|
| 66 |
Susan Shamimi-Noori. Contemporary Liver Transplantation. 2016; : 1 doi: 10.1007/978-3-319-05543-5_23-2
|
| 67 |
Andreas Koulouris, Christos Tsagkaris, Vasiliki Spyrou, Eleni Pappa, Aikaterini Troullinou, Michail Nikolaou. Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options. Journal of Hepatocellular Carcinoma 2021; : 387 doi: 10.2147/JHC.S300182
|
| 68 |
S. E. Voskanyan, A. I. Sushkov, A. I. Artemiyev, D. A. Zabezhinsky, E. V. Naydenov, A. N. Bashkov, E. S. Chuchuev, M. V. Shabalin, V. E. Syutkin. Salvage liver transplantation for hepatocellular carcinoma. Khirurgiya. Zhurnal im. N.I. Pirogova 2019; (10): 21 doi: 10.17116/hirurgia201910121
|
| 69 |
Abheek Ghosh, Vikash Gupta, Abdullah Al Khalifah, Nabeel Mohsin Akhter. Transradial versus transfemoral arterial access in DEB-TACE for hepatocellular carcinoma. Journal of Clinical Imaging Science 2022; 12: 38 doi: 10.25259/JCIS_47_2022
|
| 70 |
Hyung-Don Kim, Ju Hyun Shim, Gi-Ae Kim, Yong Moon Shin, Eunsil Yu, Sung-Gyu Lee, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee. Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization. Journal of Hepatology 2015; 62(5): 1076 doi: 10.1016/j.jhep.2014.12.013
|
| 71 |
Hayley C. Oligane, Orrie N. Close, Minzhi Xing, Hyun S. Kim. Bridging locoregional therapy: Longitudinal trends and outcomes in patients with hepatocellular carcinoma. Transplantation Reviews 2017; 31(2): 136 doi: 10.1016/j.trre.2017.01.004
|
| 72 |
Hongwei Zhao, Fuquan Liu, Zhendong Yue, Lei Wang, Zhenhua Fan, Fuliang He. Association of hepatic vein Lipiodol tram-track sign during transcatheter arterial chemoembolization with perioperative death. Journal of International Medical Research 2017; 45(3): 1148 doi: 10.1177/0300060517704141
|
| 73 |
|
| 74 |
Joseph DiNorcia, Sander S. Florman, Brandy Haydel, Parissa Tabrizian, Richard M. Ruiz, Goran B. Klintmalm, Srinath Senguttuvan, David D. Lee, C. Burcin Taner, Elizabeth C. Verna, Karim J. Halazun, Maarouf Hoteit, Matthew H. Levine, William C. Chapman, Neeta Vachharajani, Federico Aucejo, Mindie H. Nguyen, Marc L. Melcher, Amit D. Tevar, Abhinav Humar, Constance Mobley, Mark Ghobrial, Trevor L. Nydam, Beth Amundsen, James F. Markmann, Jennifer Berumen, Alan W. Hemming, Alan N. Langnas, Carol A. Carney, Debra L. Sudan, Johnny C. Hong, Joohyun Kim, Michael A. Zimmerman, Abbas Rana, Michael L. Kueht, Christopher M. Jones, Thomas M. Fishbein, Daniela Markovic, Ronald W. Busuttil, Vatche G. Agopian. Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma. Annals of Surgery 2020; 271(4): 616 doi: 10.1097/SLA.0000000000003253
|
| 75 |
Arturo Soriano, Aranzazu Varona, Rajesh Gianchandani, Modesto Enrique Moneva, Javier Arranz, Antonio Gonzalez, Manuel Barrera. Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future. World Journal of Hepatology 2016; 8(1): 58-68 doi: 10.4254/wjh.v8.i1.58
|
| 76 |
Samy Kashkoush, Sherif Saleh, Walid Elmoghazy. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_34-1
|
| 77 |
Tae-Hyung Kim, Hyoung In Choi, Bo Ram Kim, Ji Hee Kang, Ju Gang Nam, Sae Jin Park, Seunghyun Lee, Jeong Hee Yoon, Dong Ho Lee, Ijin Joo, Jeong Min Lee. No-Touch Radiofrequency Ablation of VX2 Hepatic Tumors In Vivo in Rabbits: A Proof of Concept Study. Korean Journal of Radiology 2018; 19(6): 1099 doi: 10.3348/kjr.2018.19.6.1099
|
| 78 |
Alberta Cappelli, Giuliano Peta, Rita Golfieri. Imaging of the Liver and Intra-hepatic Biliary Tract. Medical Radiology 2021; : 283 doi: 10.1007/978-3-030-39021-1_13
|
| 79 |
Gargi Kothari, Simon S. Lo, Matthew Foote, Arjun Sahgal, Irene Karam, Michael Lock, Gerrit J. Blom, Matthias Guckenberger, Ben J. Slotman, Shankar Siva. Alternate Fractionation in Radiotherapy. Medical Radiology 2017; : 323 doi: 10.1007/174_2017_38
|
| 80 |
Tony CY Pang, Vincent WT Lam. Surgical management of hepatocellular carcinoma. World Journal of Hepatology 2015; 7(2): 245-252 doi: 10.4254/wjh.v7.i2.245
|
| 81 |
Ioannis A. Ziogas, Laura A. Hickman, Lea K. Matsuoka, Manhal Izzy, Martin I. Montenovo, Scott A. Rega, Irene D. Feurer, Sophoclis P. Alexopoulos. Comparison of Wait‐List Mortality Between Cholangiocarcinoma and Hepatocellular Carcinoma Liver Transplant Candidates. Liver Transplantation 2020; 26(9): 1112 doi: 10.1002/lt.25807
|
| 82 |
Giovan Giuseppe Di Costanzo, Giampiero Francica, Claudio Maurizio Pacella. Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives. World Journal of Hepatology 2014; 6(10): 704-715 doi: 10.4254/wjh.v6.i10.704
|
| 83 |
Maurizio Pompili, Giampiero Francica. Role of ablation: should it be used as primary therapy for early-stage hepatocellular carcinoma?. Hepatic Oncology 2015; 2(4): 339 doi: 10.2217/hep.15.21
|
| 84 |
Shaakir Hasan, Stephen Abel, Tadahiro Uemura, Vivek Verma, Eugene J. Koay, Joseph Herman, Ngoc Thai, Alexander Kirichenko. Liver transplant mortality and morbidity following preoperative radiotherapy for hepatocellular carcinoma. HPB 2020; 22(5): 770 doi: 10.1016/j.hpb.2019.10.006
|
| 85 |
Samy Kashkoush, Sherif Saleh, Walid Elmoghazy. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 837 doi: 10.1007/978-94-007-7675-3_34
|
| 86 |
Roberto Minici, Michele Ammendola, Francesco Manti, Maria Anna Siciliano, Enrica Giglio, Marco Minici, Marica Melina, Giuseppe Currò, Domenico Laganà. Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization as a Bridging Therapy in Patients with Early Stage Hepatocellular Carcinoma and Child-Pugh Stage B Eligible for Liver Transplant. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.634084
|